Apimeds Pharmaceuticals US (APUS US)

Analysis

Health Care • United States

Apimeds Pharmaceuticals US, Inc. is a clinical stage biopharmaceutical company. The Company specializes in developing an intradermally administered bee venom-based toxin which exhibits diverse therapeutic effects. Apimeds Pharmaceuticals US operates in the United States.

Refresh

Focused

No publications yet

There aren’t any broker reports right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00